Influenza A Virus Infection of Human Respiratory Cells Induces Primary MicroRNA Expression

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Jul 24

PMID 22822053

Citations 65

Authors

William A Buggele

Karen E Johnson

Curt M Horvath

Affiliations

Soon will be listed here.

Abstract

The cellular response to virus infection is initiated by recognition of the invading pathogen and subsequent changes in gene expression mediated by both transcriptional and translational mechanisms. In addition to well established means of regulating antiviral gene expression, it has been demonstrated that RNA interference (RNAi) can play an important role in antiviral responses. Virus-derived small interfering RNA (siRNA) is a primary antiviral response exploited by plants and invertebrate animals, and host-encoded microRNA (miRNA) species have been clearly implicated in the regulation of innate and adaptive immune responses in mammals and other vertebrates. Examination of miRNA abundance in human lung cell lines revealed endogenous miRNAs, including miR-7, miR-132, miR-146a, miR-187, miR-200c, and miR-1275, to specifically accumulate in response to infection with two influenza A virus strains, A/Udorn/72 and A/WSN/33. Known antiviral response pathways, including Toll-like receptor, RIG-I-like receptor, and direct interferon or cytokine stimulation did not alter the abundance of the tested miRNAs to the extent of influenza A virus infection, which initiates primary miRNA transcription via a secondary response pathway. Gene expression profiling identified 26 cellular mRNAs targeted by these miRNAs, including IRAK1, MAPK3, and other components of innate immune signaling systems.

Citing Articles

Circulating miRNAs in the Plasma of Post-COVID-19 Patients with Typical Recovery and Those with Long-COVID Symptoms: Regulation of Immune Response-Associated Pathways.

Timofeeva A, Nikitin A, Nevinsky G Noncoding RNA. 2024; 10(5).

PMID: 39311385 PMC: 11417918. DOI: 10.3390/ncrna10050048.

Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection.

Chaudhary R, Meher A, Krishnamoorthy P, Kumar H Curr Res Immunol. 2023; 4:100062.

PMID: 37273890 PMC: 10238879. DOI: 10.1016/j.crimmu.2023.100062.

Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.

Redensek Trampuz S, Vogrinc D, Goricar K, Dolzan V Front Mol Neurosci. 2023; 16:1123955.

PMID: 37008787 PMC: 10064073. DOI: 10.3389/fnmol.2023.1123955.

Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals.

Ostrycharz E, Hukowska-Szematowicz B Int J Mol Sci. 2022; 23(18).

PMID: 36142450 PMC: 9504570. DOI: 10.3390/ijms231810536.

Differing coronavirus genres alter shared host signaling pathways upon viral infection.

Cruz-Pulido D, Ouma W, Kenney S Sci Rep. 2022; 12(1):9744.

PMID: 35697915 PMC: 9189807. DOI: 10.1038/s41598-022-13396-7.

References

Loveday E, Svinti V, Diederich S, Pasick J, Jean F . Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection. J Virol. 2012; 86(11):6109-22. PMC: 3372180. DOI: 10.1128/JVI.06892-11. View

Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne R . miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol. 2010; 12(5):513-9. DOI: 10.1038/ncb2054. View

Jopling C . Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans. 2008; 36(Pt 6):1220-3. DOI: 10.1042/BST0361220. View

Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H . Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med. 2007; 13(10):1241-7. DOI: 10.1038/nm1639. View

Gack M, Albrecht R, Urano T, Inn K, Huang I, Carnero E . Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009; 5(5):439-49. PMC: 2737813. DOI: 10.1016/j.chom.2009.04.006. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Huntzinger E, Izaurralde E . Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011; 12(2):99-110. DOI: 10.1038/nrg2936. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K . Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006; 441(7089):101-5. DOI: 10.1038/nature04734. View

10.

Thomson J, Newman M, Parker J, Morin-Kensicki E, Wright T, Hammond S . Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006; 20(16):2202-7. PMC: 1553203. DOI: 10.1101/gad.1444406. View

11.

Lim L, Lau N, Garrett-Engele P, Grimson A, Schelter J, Castle J . Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433(7027):769-73. DOI: 10.1038/nature03315. View

12.

Bamming D, Horvath C . Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J Biol Chem. 2009; 284(15):9700-12. PMC: 2665091. DOI: 10.1074/jbc.M807365200. View

13.

Song L, Liu H, Gao S, Jiang W, Huang W . Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol. 2010; 84(17):8849-60. PMC: 2919005. DOI: 10.1128/JVI.00456-10. View

14.

Hale B, Randall R, Ortin J, Jackson D . The multifunctional NS1 protein of influenza A viruses. J Gen Virol. 2008; 89(Pt 10):2359-2376. DOI: 10.1099/vir.0.2008/004606-0. View

15.

Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y . MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009; 60(4):1065-75. DOI: 10.1002/art.24436. View

16.

Dweep H, Sticht C, Pandey P, Gretz N . miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011; 44(5):839-47. DOI: 10.1016/j.jbi.2011.05.002. View

17.

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

18.

Rehwinkel J, Behm-Ansmant I, Gatfield D, Izaurralde E . A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA. 2005; 11(11):1640-7. PMC: 1370850. DOI: 10.1261/rna.2191905. View

19.

Pedersen I, Cheng G, Wieland S, Volinia S, Croce C, Chisari F . Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007; 449(7164):919-22. PMC: 2748825. DOI: 10.1038/nature06205. View

20.

Siren J, Imaizumi T, Sarkar D, Pietila T, Noah D, Lin R . Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect. 2006; 8(8):2013-20. DOI: 10.1016/j.micinf.2006.02.028. View